Summary
COSYN was a state-of-art, bench-to-bedside programme focused on personalised therapeutics. COSYN integrated outstanding European academic and two large Pharma partners to exploit genomic findings for intellectual disability (ID), autism (ASD), and schizophrenia (SCZ). We...
More information & hyperlinks
Web resources: | http://www.cosyn-precisionmedicine.eu |